May 17, 2018 5:52pm

Q1/18 financial results also known as (AKA) earnings is a ‘scorecard’ of public stem, cell, gene therapies and editing, regenerative therapy and a couple of CNS and RNAi companies.

The current LPS (loss per share) standings reflect the universes’ investing status; then add in their cash position for a better snapshot!

By analyzing these comparisons, investors can begin to gauge the financial health versus the scientific opportunity and whether or not it deserves their investment.

 


COMPANY SYMBOL NET INCOME Q1/18 LOSS Q1/18 LPS Q1/18 CASH  RUNWAY
             
Aduro Biotech, Inc. ADRO   -$21.5 M -$0.28 $327.8 M  
Alnylam Pharmaceuticals ALNY   -$141.2 M -$1.41 $1.568 B  
Applied Genetic Technologies AGTC   -$8.1 M -$0.45 $11.8 M  
Asterias Biotherapeutics AST   -$2.3 M -$0.04 $18.8 M  
Athersys, Inc. ATHX   -$10.2 M -$0.63
$49.78 M
+$10 M (Helios)
 
Adverum Biotechnologies, Inc. ADVM   -$17.2 M -$0.30 $247 M  
Audentes Therapeutics BOLD   -$25.6 M -$0.74 $326.1 M  
AxoGen, Inc. AXGN   -$5.6 M -$0.16 $30.6 M  
Bellicum Pharmaceuticals, Inc. BLCM   -$22.8 M -$0.68 $88 M  
BioLife Solutions, Inc. BLFS   -$103 K -$0.01 $7 M  
BioMarin Pharmaceuticals BMRN   -$44.1 M -$0.26 $1.7 B  
Biostage, Inc. BSTG   -$1.59 M -$0.56 $2.8 M  
BioTime, Inc. BTX   -$63.5 M -$0.50 $31.4 M  
bluebird bio BLUE   -$115.1 M -$2.31 $1.57 B  
Brainstorm Cell Therapeutics Inc. BCLI   -$2.3 M -$0.12
$6.6 M
$2 M (CIRM)
 
Caladrius Biosciences. CLBS   -$5 M -$0.52 $53.6 M  
Cellectis SA CLLS   -$19.8 M -$0.56 $282.1 M  
Cesca Therapeutics, Inc KOOL   -$3 M -$0.27 $2.87 M  
CRISPR Therapeutics CRSP   -$28.3 M -$0.62 $341.8 M  
Editas Medicine EDIT   -$30.9 M -$0.67 $359 M  
Fate Therapeutics, Inc. FATE   -$14.1 M -$0.27 $88.6 M  
Global Blood Therapeutics GBT   -$41.6 M -$0.87 $544.6 M  
Histogenics Corporation HSGX   $14.4 M -$0.52 $15.5 M  
Homology Medicine FIXX   -$10.5 M -$4.21
$116.7 M
+$151 M (IPO)
 
Intellia Therapeutics NTLA   -$21.4 M -$0.21 $327.8 M  
Intrexon Corporation XON   -$42 M -$0.33 $120.2 M  
Ionis Pharmaceuticals IONS   -$10.8 M -$0.01 $1 B  
Mesoblast Limited MESO          
MiMedx Group, Inc MDXG          
Neuralstem, Inc.  CUR   -$2.1 M -$0.14 $9.7 M  
Organovo Holdings, Inc. ONVO          
Osiris Therapeutics, Inc. OSIR   -$2,32 M -$0.07 $27.86 M  
Pluristem Therapeutics, Inc. PSTI   -$1.5 M -$0.01 $34.1 M  
ReNeuron Group PLC RENE.L          
Regenxbio RGNX +$104.2 M or +$3.04 -   $235.8 M  
Sage Therapeutics SAGE   -$74.6 M -$1.68 $518.8 M  
Sangamo Biosciences, Inc. SGMO   -$20.2 M -$0.23
$234.9 M
Post Q- $600.9 M
 
Solid Biosciences SLDB   -$5.9 M -$0.54 $182.4 M  
Spark Therapeutics, Inc. ONCE   -$46.4 M -$1.25 $587.5 M  
Stemline Therapeutics, Inc. STML   -$18.4 M -$0.69 $106.2 M  
Ultragenyx RARE +$30.3 M or +$0.63     $571.3 M  
uniQure N.V. QURE   -$18.8 M -$0.59  $140.8 M  
Verastem, Inc. VSTM   -$.21 M -$0.41 $65.2 M  
Vericel Corporation VCEL   -$7.7 M -$0.21 $29.8 M  
Voyager Therapeutics VYGR   -$19.9 M -$0.63 $218.2 M